Re: Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia

被引:4
|
作者
Vargas, RL [1 ]
Felgar, RE [1 ]
Rothberg, PG [1 ]
机构
[1] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2005年 / 97卷 / 14期
关键词
D O I
10.1093/jnci/dji119
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1089 / 1090
页数:2
相关论文
共 50 条
  • [21] MNDA controls the expression of MCL-1 and BCL-2 in chronic lymphocytic leukemia cells
    Bottardi, Stefania
    Guieze, Romain
    Bourgoin, Vincent
    Fotouhi-Ardakani, Nasser
    Douge, Aurore
    Darracq, Anais
    Lakehal, Yahia A.
    Berger, Marc G.
    Mollica, Luigina
    Bay, Jacques-Olivier
    Omichinski, James G.
    Milot, Eric
    EXPERIMENTAL HEMATOLOGY, 2020, 88 : 68 - +
  • [22] AMG-176, an Mcl-1 Antagonist, Shows Preclinical Efficacy in Chronic Lymphocytic Leukemia
    Yi, Xue
    Sarkar, Aloke
    Kismali, Gorkem
    Aslan, Burcu
    Ayres, Mary
    Iles, LaKesla R.
    Keating, Michael J.
    Wierda, William G.
    Long, James P.
    Bertilaccio, Maria Teresa Sabrina
    Gandhi, Varsha
    CLINICAL CANCER RESEARCH, 2020, 26 (14) : 3856 - 3867
  • [23] Regulation of Mcl-1 Expression in Context to Bone Marrow Stromal Microenvironment in Chronic Lymphocytic Leukemia
    Balakrishnan, Kumudha
    Burger, Jan A.
    Fu, Min
    Doifode, Tejaswini
    Wierda, William G.
    Gandhi, Varsha
    NEOPLASIA, 2014, 16 (12): : 1036 - 1046
  • [24] Homoharringtonine down-regulates Mcl-1 and induces apoptosis in chronic lymphocytic leukemia cells
    Guo, Lei
    Chen, Rong
    Wierda, William
    Plunkett, William
    CANCER RESEARCH, 2009, 69
  • [25] Myeloid cell factor (Mcl-1) expression and drug sensitivity in chronic lymphocytic leukemia.
    Paul, JT
    Johnston, JB
    Neufeld, NJ
    Kropp, DM
    Hu, XJ
    Gibson, SB
    BLOOD, 2002, 100 (11) : 354B - 354B
  • [26] c-Abl regulates Mcl-1 gene expression in chronic lymphocytic leukemia cells
    Allen, John C.
    Talab, Fatima
    Zuzel, Mirko
    Lin, Ke
    Slupsky, Joseph R.
    BLOOD, 2011, 117 (08) : 2414 - 2422
  • [27] MCL-1 gene promoter insertions do not correlate with disease outcome, stage or VH gene mutation status in chronic lymphocytic leukemia
    Tobin, G
    Skogsberg, A
    Thunberg, U
    Laurell, A
    Åleskog, A
    Merup, M
    Sundstrom, C
    Roos, GG
    Nilsson, K
    Rosenquist, R
    ANNALS OF ONCOLOGY, 2005, 16 : 200 - 200
  • [28] Polymorphisms in the promoter region of the Mcl-1 gene are associated with ex vivo cytotoxicity but not with response to treatment in advanced chronic lymphocytic leukemia (CLL).
    Villamor, N
    Marce, S
    Bosch, F
    Ferrer, A
    Pérez-Galán, P
    López-Guillermo, A
    Giné, E
    Campo, E
    Montserrat, E
    Colomer, D
    BLOOD, 2005, 106 (11) : 329B - 329B
  • [29] Targeting SF3B1 mediated splicing control of Mcl-1 in chronic lymphocytic leukemia
    Chen, Rong
    Chen, Yuling
    Ghia, Emanuela M.
    Rassenti, Laura
    Kipps, Thomas
    Keating, Michael J.
    Wierda, William G.
    Plunkett, William
    CANCER RESEARCH, 2014, 74 (19)
  • [30] Tipping the Noxa/Mcl-1 Balance Overcomes ABT-737 Resistance in Chronic Lymphocytic Leukemia
    Tromp, Jacqueline M.
    Geest, Christian R.
    Breij, Esther C. W.
    Elias, Judith A.
    van Laar, Jacoline
    Luijks, Dieuwertje M.
    Kater, Arnon P.
    Beaumont, Tim
    van Oers, Marinus H. J.
    Eldering, Eric
    CLINICAL CANCER RESEARCH, 2012, 18 (02) : 487 - 498